Jefferies Financial Group Inc. Dexcom Inc Call Options Transaction History

Jefferies Financial Group Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	SELL	$114.22 - $140.1 $1.71 Million - $2.1 Million	-15,000 Reduced 37.5%	25,000 $3.47 Million
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $3.02 Million - $4.97 Million	40,000 New	40,000 $4.96 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $4.29 Million - $4.99 Million	-38,100 Reduced 97.19%	1,100 $141,000
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $4.08 Million - $4.82 Million	39,200 New	39,200 $4.55 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.